NEW YORK (GenomeWeb) — Cepheid reported after the close of market on Thursday a 15 percent spike in third quarter revenues as the company beat consensus analyst estimates on both the top and bottom lines.

For the three months ended September 30, Cepheid logged revenues of $115.2 million, a 14 percent increase over $100.1 million in the same quarter last year, and beating the average Wall Street estimate of $110 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

New Mexico is re-doing its proposed science education standards after criticism, the Associated Press reports.

Agbio executives say gene editing will speed up breeding efforts, according to the Wall Street Journal.

La Trobe University's Jenny Graves has won the $250,000 Prime Minister's Prize for Science, the Guardian reports.

In Cell this week: post-treatment changes to melanoma genome, multi-omics analysis of muscle-invasive bladder cancer, and more.